Wall Street's small-cap guru sees a 2021 rally, but without the 'euphoria' of mega-tech

A passenger boards an Avis shuttle bus at Los Angeles International Airport.
Patrick T. Fallon | Bloomberg | Getty Images

(This story is for CNBC Pro subscribers only.)

Small-caps are outperforming during the vaccine-induced rally as investors ditch technology heroes for cyclical stocks whose outperformance hinges on a strengthening economy.

The small-cap benchmark, the Russell 2000, is up more than 5% this week following Pfizer's news that it had developed a Covid-19 vaccine with a better than 90% success rate in tests. Investors digested the news by rotating out of growth stocks and into those most beaten down by the pandemic.

However, Wall Street small-cap market guru Steven DeSanctis said the group of cyclicals has been silently grinding higher since the start of the pandemic, with many signs pointing to a strong 2021.

More In Investing trends

CNBC ProIf the 2014 Fed taper is any guide, it's time for investors to get defensive
CNBC ProGoldman says buy these stocks with expanding margins as higher costs hit most companies
CNBC ProGoldman Sachs says $3.2 trillion worth of Chinese stocks at risk of further regulatory crackdown